WASHINGTON (AP) — The Food and Drug Administration has approved a new long-acting inhaler drug from Boehringer Ingelheim to treat people with chronic lung disease. The agency approved Striverdi Respimat for chronic obstructive pulmonary disease, which causes bronchitis and emphysema and affects about 24 million people in the U.S. The disease, which is most often caused by smoking, is the third leading cause of death in the U.S., according to the National Institutes of Health. The FDA approved the drug on Thursday based on a study in 3,104 patients which showed improvements in lung function versus placebo. The drug will carry a bold warning that it is not approved to treat patients with asthma.Read more on NewsOK.com
Fda Approves Boehringer's Once-a-day Inhaler Drug
NewsOK.com RSS - business, Daily Oklahoman: Business
Thu, 07/31/2014 - 12:16pm
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more